...
首页> 外文期刊>Clinical Cancer Drugs >Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer
【24h】

Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer

机译:胰腺癌侵袭和转移的新分子靶点和机制

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related deaths and its morbidity and mortality are increasing. PDAC patients have a very poor prognosis because of aggressive features of PDAC cells, shortage of reliable diagnostic biomarkers and deficiency of effective therapeutics. Objective: The article aims to discuss the recent progress in the discovery of novel molecular targets and their related mechanisms in the invasion and metastasis of PDAC cells. Methods: Literatures based on Pubmed database were searched and those related to the molecular targets involved in the invasion and metastasis of PDAC were reviewed. Results: The most promising discovery of molecular targets and phenomena include epithelial-mesenchymal transition (EMT), cancer stem cells (CSCs), metastasis-related genes, hypoxia-inducible factors (HIFs), non-coding RNAs (ncRNAs) and L1 cell adhesion molecule (L1CAM), which contribute to the vital biological behaviors of PDAC cells and tumor microenvironments. Conclusion: This review summarizes recent advances in novel molecular targets that regulate the invasion and metastasis of PDAC cells, and how they are targeted for developing diagnostic and therapeutic tools for combating PDAC. Further understanding the regulatory mechanisms of these molecular targets may help to discover biomarkers used for early diagnosis, predicting the prognosis and monitoring treatment response, and also to develop novel effective therapeutics.
机译:背景:胰腺导管腺癌(PDAC)是癌症相关死亡的主要原因,其发病率和死亡率正在增加。 PDAC患者预后具有非常差的预后,因为PDAC细胞的激进特征,可靠的诊断生物标志物和有效治疗缺乏的缺乏。目的:该文章旨在讨论发现新型分子靶标的最近进展及其在PDAC细胞侵袭和转移中的相关机制。方法:搜查了基于PubMed数据库的文献,综述了与PDAC侵袭和转移的分子靶标相关的文献。结果:最有希望的分子靶标和现象的发现包括上皮 - 间充质转换(EMT),癌症干细胞(CSC),转移相关基因,缺氧诱导因子(HIF),非编码RNA(NCRNA)和L1细胞粘附分子(L1CAM),其有助于PDAC细胞和肿瘤微环境的重要生物学行为。结论:本综述总结了调节PDAC细胞侵袭和转移的新型分子靶标的最近进展,以及它们如何旨在开发用于打击PDAC的诊断和治疗工具。进一步了解这些分子靶标的调节机制可能有助于发现用于早期诊断的生物标志物,预测预后和监测治疗反应,以及开发新的有效治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号